VAPB and C9orf72 mutations in 1 familial amyotrophic lateral sclerosis patient

Neurobiology of Aging

Volumn 33, Issue 12, 2012, Pages 2950.e1-2950.e4

  van Blitterswijk, Marka ^a   van Es, Michael A ^a   Koppers, Max ^a   van Rheenen, Wouter ^a   Medic, Jelena ^a   Schelhaas, Helenius J ^b   van der Kooi, Anneke J ^c   de Visser, Marianne ^c   Veldink, Jan H ^a   van den Berg, Leonard H ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b RADBOUD UNIVERSITY   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Amyotrophic lateral sclerosis; C9orf72; Familial ALS; Genetics; Motor neuron disease; VAPB

Indexed keywords

SYNAPTOBREVIN; UNCLASSIFIED DRUG; VESICLE ASSOCIATED MEMBRANE PROTEIN B;

AGED; ALPHA HELIX; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CHROMOSOME 9 OPEN READING FRAME GENE; CONTROLLED STUDY; EXON; FEMALE; GENE; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC CONSERVATION; GENETIC SCREENING; HUMAN; LIMB WEAKNESS; MAJOR CLINICAL STUDY; MOLECULAR PATHOLOGY; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SENSITIVITY AND SPECIFICITY; VESICLE ASSOCIATED MEMBRANE PROTEIN B GENE;

EID: 84866766416     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2012.07.004     Document Type: Article

References (19)

1. Brooks B.R., Miller R.G., Swash M., Munsat T.L. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Mot. Neuron Disord 2000, 1:293-299.
2. Chen H.J., Anagnostou G., Chai A., Withers J., Morris A., Adhikaree J., Pennetta G., de Belleroche J.S. Characterization of the properties of a novel mutation in VAPB in familial amyotrophic lateral sclerosis. J. Biol. Chem 2010, 285:40266-40281.
3. Chiò A., Restagno G., Brunetti M., Ossola I., Calvo A., Canosa A., Moglia C., Floris G., Tacconi P., Marrosu F., Marrosu M.G., Murru M.R., Majounie E., Renton A.E., Abramzon Y., Pugliatti M., Sotgiu M.A., Traynor B.J., Borghero G. ALS/FTD phenotype in two Sardinian families carrying both C9ORF72 and TARDBP mutations. J. Neurol. Neurosurg. Psychiatry 2012, 83:730-733. SARDINIALS Consortium.
4. Conforti F.L., Sprovieri T., Mazzei R., Ungaro C., Tessitore A., Tedeschi G., Patitucci A., Magariello A., Gabriele A., Labella V., Simone I.L., Majorana G., Monsurro M.R., Valentino P., Muglia M., Quattrone A. Sporadic ALS is not associated with VAPB gene mutations in Southern Italy. J. Negat. Results Biomed 2006, 5:7.
5. Dejesus-Hernandez M., Mackenzie I.R., Boeve B.F., Boxer A.L., Baker M., Rutherford N.J., Nicholson A.M., Finch N.A., Flynn H., Adamson J., Kouri N., Wojtas A., Sengdy P., Hsiung G.Y., Karydas A., Seeley W.W., Josephs K.A., Coppola G., Geschwind D.H., Wszolek Z.K., Feldman H., Knopman D.S., Petersen R.C., Miller B.L., Dickson D.W., Boylan K.B., Graff-Radford N.R., Rademakers R. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 2011, 72:245-256.
6. Funke A.D., Esser M., Krüttgen A., Weis J., Mitne-Neto M., Lazar M., Nishimura A.L., Sperfeld A.D., Trillenberg P., Senderek J., Krasnianski M., Zatz M., Zierz S., Deschauer M. The p.P56S mutation in the VAPB gene is not due to a single founder: the first European case. Clin. Genet 2010, 77:302-303.
7. Gkogkas C., Middleton S., Kremer A.M., Wardrope C., Hannah M., Gillingwater T.H., Skehel P. VAPB interacts with and modulates the activity of ATF6. Hum. Mol. Genet 2008, 17:1517-1526.
8. Kanekura K., Suzuki H., Aiso S., Matsuoka M. ER stress and unfolded protein response in amyotrophic lateral sclerosis. Mol. Neurobiol 2009, 39:81-89.
9. Landers J.E., Leclerc A.L., Shi L., Virkud A., Cho T., Maxwell M.M., Henry A.F., Polak M., Glass J.D., Kwiatkowski T.J., Al-Chalabi A., Shaw C.E., Leigh P.N., Rodriguez-Leyza I., McKenna-Yasek D., Sapp P.C., Brown R.H. New VAPB deletion variant and exclusion of VAPB mutations in familial ALS. Neurology 2008, 70:1179-1185.
10. Lev S., Ben Halevy D., Peretti D., Dahan N. The VAP protein family: from cellular functions to motor neuron disease. Trends Cell Biol 2008, 18:282-290.
11. Marques V.D., Barreira A.A., Davis M.B., Abou-Sleiman P.M., Silva W.A., Zago M.A., Sobreira C., Fazan V., Marques W. Expanding the phenotypes of the Pro56Ser VAPB mutation: proximal SMA with dysautonomia. Muscle Nerve 2006, 34:731-739.
12. Millecamps S., Salachas F., Cazeneuve C., Gordon P., Bricka B., Camuzat A., Guillot-Noël L., Russaouen O., Bruneteau G., Pradat P.F., Le Forestier N., Vandenberghe N., Danel-Brunaud V., Guy N., Thauvin-Robinet C., Lacomblez L., Couratier P., Hannequin D., Seilhean D., Le Ber I., Corcia P., Camu W., Brice A., Rouleau G., Leguern E., Meininger V. SOD1, ANG, VAPB, TARDBP, and FUS mutations in familial amyotrophic lateral sclerosis: genotype-phenotype correlations. J. Med. Genet 2010, 47:554-560.
13. Nickerson D.A., Tobe V.O., Taylor S.L. PolyPhred: automating the detection and genotyping of single nucleotide substitutions using fluorescence-based resequencing. Nucleic Acids Res 1997, 25:2745-2751.
14. Nishimura A.L., Mitne-Neto M., Silva H.C., Richieri-Costa A., Middleton S., Cascio D., Kok F., Oliveira J.R., Gillingwater T., Webb J., Skehel P., Zatz M. A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. Am. J. Hum. Genet 2004, 75:822-831.
15. Price A.L., Kryukov G.V., de Bakker P.I., Purcell S.M., Staples J., Wei L.J., Sunyaev S.R. Pooled association tests for rare variants in exon-resequencing studies. Am. J. Hum. Genet 2010, 86:832-838.
16. Renton A.E., Majounie E., Waite A., Simón-Sánchez J., Rollinson S., Gibbs J.R., Schymick J.C., Laaksovirta H., van Swieten J.C., Myllykangas L., Kalimo H., Paetau A., Abramzon Y., Remes A.M., Kaganovich A., Scholz S.W., Duckworth J., Ding J., Harmer D.W., Hernandez D.G., Johnson J.O., Mok K., Ryten M., Trabzuni D., Guerreiro R.J., Orrell R.W., Neal J., Murray A., Pearson J., Jansen I.E., Sondervan D., Seelaar H., Blake D., Young K., Halliwell N., Callister J.B., Toulson G., Richardson A., Gerhard A., Snowden J., Mann D., Neary D., Nalls M.A., Peuralinna T., Jansson L., Isoviita V.M., Kaivorinne A.L., Holtta-Vuori M., Ikonen E., Sulkava R., Benatar M., Wuu J., Chio A., Restagno G., Borghero G., Sabatelli M., Heckerman D., Rogaeva E., Zinman L., Rothstein J.D., Sendtner M., Drepper C., Eichler E.E., Alkan C., Abdullaev Z., Pack S.D., Dutra A., Pak E., Hardy J., Singleton A., Williams N.M., Heutink P., Pickering-Brown S., Morris H.R., Tienari P.J., Traynor B.J. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 2011, 72:257-268. ITALSGEN Consortium.
17. Tudor E.L., Galtrey C.M., Perkinton M.S., Lau K.F., De Vos K.J., Mitchell J.C., Ackerley S., Hortobágyi T., Vámos E., Leigh P.N., Klasen C., McLoughlin D.M., Shaw C.E., Miller C.C. Amyotrophic lateral sclerosis mutant vesicle-associated membrane protein-associated protein-B transgenic mice develop TAR-DNA-binding protein-43 pathology. Neuroscience 2010, 167:774-785.
18. van Blitterswijk M., van Es M.A., Hennekam E.A.M., Dooijes D., van Rheenen W., Medic J., Bourque P.R., Schelhaas H.J., van der Kooi A.J., de Visser M., de Bakker P.I.W., Veldink J.H., van den Berg L.H. Evidence for an oligogenic basis of amyotrophic lateral sclerosis. Hum. Mol. Genet 2012 June 16, [Epub]. 10.1093/hmg/dds199.
19. van Rheenen W., van Blitterswijk M., Huisman M.H.B., Vlam L., van Doormaal P.T.C., Seelen M., Medic J., Dooijes D., de Visser M., van der Kooi A.J., Raaphorst J., Schelhaas H.J., van der Pol W.L., Veldink J.H., van den Berg L.H. Hexanucleotide repeat expansions in C9orf72 in the spectrum of motor neuron diseases. Neurology 2012 July 25, [Epub]. 10.1212/WNL.0b013e3182661d14.